# FDA recall Z-0132-2025

> **Medtronic Neuromodulation** · Class II · device recall initiated 2024-08-21.

## Product

Vanta Implantable Neurostimulator (INS), Model 977006

## Reason for recall

Model 977006 Vanta INS batterty life has depleted faster than HCPs or patients expected leading to outpatient reprogramming or earlier than anticipated surgical replacements.

## Distribution

Worldwide distribution.

## Key facts

- **Recall number:** Z-0132-2025
- **Recalling firm:** Medtronic Neuromodulation
- **Classification:** Class II
- **Product type:** device
- **Status:** Ongoing
- **Initiation date:** 2024-08-21
- **Report date:** 2024-10-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Minneapolis, MN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0132-2025

## Citation

> AI Analytics. FDA recall Z-0132-2025. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/Z-0132-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*